SWStonkWhisper
← Back to Intel
Insider ActivityTMCI

Treace John T., Chief Executive Officer at TREACE MEDICAL CONCEPTS, INC., bought $121K of TMCI

Last updated Aug 12, 2026

This page documents an SEC Form 4 insider trading disclosure for $TMCI securities filed with the Securities and Exchange Commission. Section 16 of the Securities Exchange Act of 1934 mandates that corporate officers, directors, and beneficial owners of more than 10% of a company's registered equity securities must report their personal trades within two business days of execution. Insider transactions are closely monitored by market participants because insiders possess firsthand knowledge of company operations, financial condition, and near-term prospects. The transaction details below are drawn directly from the SEC EDGAR filing database and reflect the information as reported.

Treace John T. Chief Executive Officer
TREACE MEDICAL CONCEPTS, INC. · $TMCI
$121K Total Value
49,013 Shares Traded
$2.4592 Price / Share
7,096,563 Shares Owned After
2026-05-14 Filing Date

Transaction Details

InsiderTreace John T.
TitleChief Executive Officer
CompanyTREACE MEDICAL CONCEPTS, INC.
TickerTMCI
Transaction TypePurchase
Transaction Date2026-05-13
Shares Traded49,013
Price Per Share$2.4592
Total Value$121K
Filed Date2026-05-14
Accession Number0001193125-26-224391

Ownership Context

Shares Owned After Transaction7,096,563
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001193125-26-224391

Other Insider Trades — TMCI

Other Trades by Treace John T.

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for TMCI — TREACE MEDICAL CONCEPTS, INC. →

Track TMCI insider activity in real time on The Wire →

Get alerts when Treace John T. files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: August 12, 2026 at 07:29 UTC

Not Financial Advice: This article is for informational and educational purposes only and does not constitute financial advice, investment advice, or a recommendation to buy or sell any security. StonkWhisper aggregates publicly available data from verified regulatory filings and proprietary analysis pipelines. All investment decisions are made solely at your own risk. Guerilla Finance LLC is not a registered investment advisor or broker-dealer. Always consult a qualified financial professional before making investment decisions.

Want real-time data? Access The Wire for live sentiment tracking.